Targeted OncologyLiso-Cel Demonstrates "Remarkable" Activity, Lower Toxicity in Patients With DLBCLTargeted OncologyMaloney: JCAR017 is a CAR T-cell product directed against CD19. This is in multicenter clinical trials in aggressive large B-c… Continue reading
Medical XpressStudy in mice suggests personalized stem cell treatment may offer relief for multiple sclerosisMedical XpressA particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, t… Continue reading
FierceBiotechA personalized MS treatment built from skin stem cellsFierceBiotechProgressive forms of multiple sclerosis occur when immune cells called microglia attack the central nervous system, damaging the protective myelin sheath around nerve cells… Continue reading
EurekAlert (press release) |
Sandhoff disease study shows proof of principle for gene therapy
EurekAlert (press release) A paper appearing in the March 1 issue of the Journal of Lipid Research by senior investigators Tifft and Richard Proia and lead author Laura Allende of NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and their colleagues … |
|
Sandhoff disease study shows proof of principle for gene therapy
EurekAlert (press release) A paper appearing in the March 1 issue of the Journal of Lipid Research by senior investigators Tifft and Richard Proia and lead author Laura Allende of NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and their colleagues … |
EurekAlert (press release) |
Sandhoff disease study shows proof of principle for gene therapy
EurekAlert (press release) A paper appearing in the March 1 issue of the Journal of Lipid Research by senior investigators Tifft and Richard Proia and lead author Laura Allende of NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and their colleagues … |